Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 7  Issue 2
Is nitric oxide nociceptive or antinociceptive?
Vinicio Granados-Soto
Pages: 209 - 218
Number of pages: 10
Current Topics in Pharmacology
Volume 7  Issue 2

Copyright © 2003 Research Trends. All rights reserved


Nitric oxide (NO), a second messenger produced by the enzyme NO synthase (NOS), is involved in peripheral and central pain mechanisms. The effect of NO on pain is controversial. There is evidence to support a pronociceptive activity of NO. Thus, intradermal injection of L-arginine or NO donors, but not D-arginine, produced mechanical hyperalgesia. In addition, local administration of NOS inhibitors is able to block bradykinin- and formalin –induced pain, acetic-acid-induced abdominal writhing, PGE2- induced mechanical hyperalgesia and carrageenin-induced thermal hyperalgesia. In other cases, there is evidence to support an antinociceptive action for NO. L- arginine caused antinociception in carrageenan-induced  hyperalgesia. This antinociception was blocked by either NOS or guanylyl cyclase inhibitors and potentiated by inhibitors of cyclic GMP phosphodiesterase. In addition, the antinociceptive activity of several antinociceptive drugs (morphine, metamizol, diclofenac, ketorolac and meloxicam) is dose-dependently reduced by NOS and soluble guanylyl cylase inhibitors. These data suggest that NO-cyclic GMP pathway at the periphery play an important role in antinociception. Recent pharmacological data suggest that opening of K+ channels is also an important step in the mechanism of action that leads to antinociception by some drugs that activate the NO-cyclic GMP pathway. The participation of different systems, such as the NO- cyclic GMP-K+ channel pathway, would allow development of new therapies to relief inflammatory or neruopathic pain.

Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms